Skip to main content
Top
Published in: Supportive Care in Cancer 7/2011

01-07-2011 | Original Article

Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation

Authors: Yoshihiko Soga, Yoshinobu Maeda, Fumihiko Ishimaru, Mitsune Tanimoto, Hiroshi Maeda, Fusanori Nishimura, Shogo Takashiba

Published in: Supportive Care in Cancer | Issue 7/2011

Login to get access

Abstract

Purpose

Coagulase-negative staphylococci (CoNS) are frequently isolated from blood cultures of hematopoietic cell transplantation (HCT) patients. Generally, the use of central venous catheters is recognized as a significant risk factor for CoNS infection, while the impact of CoNS infection from oral ulcerative mucositis, which occurs frequently in HCT, may be underestimated. Here, we examined the bacteria on the buccal mucosa after HCT.

Methods

Sixty-one patients were examined for bacteria on the buccal mucosa routinely once a week from 1 week before to 3 weeks after allogeneic HCT. Subjects were divided into groups with short and long periods of antibiotic use, and differences in bacterial substitution were evaluated. The relationships between type of HCT (conventional HCT or RIST) and bacterial substitution were also evaluated.

Results

The changes in detection frequencies of CoNS and α-streptococci from before to 3 weeks after HCT were significant (P < 0.05, χ 2 test): 14.5–53.3% and 92.7–53.1%, respectively. Significant bacterial substitution of CoNS for streptococci was observed in the long-term antibiotic use group (P < 0.05, χ 2 test), but also occurred in cases with short-term or no antibiotic use. No relationships between type of HCT (conventional HCT or RIST) were observed.

Conclusion

Bacterial substitution of CoNS for streptococci occurred frequently on the buccal mucosa after HCT. In addition to antibiotic use, environmental factors may be involved in bacterial substitution. It is important to consider the presence of oral mucositis in CoNS infection after HCT.
Literature
1.
go back to reference López Dupla M, Martinez JA, Vidal F et al (2005) Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes. J Intern Med 258:172–180PubMedCrossRef López Dupla M, Martinez JA, Vidal F et al (2005) Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes. J Intern Med 258:172–180PubMedCrossRef
2.
go back to reference Kloos WE, Bannerman TL (1994) Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 7:117–140PubMed Kloos WE, Bannerman TL (1994) Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 7:117–140PubMed
3.
go back to reference Weinstein MP, Towns ML, Quartey SM et al (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602PubMed Weinstein MP, Towns ML, Quartey SM et al (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602PubMed
4.
go back to reference Herwaldt LA, Magdalena G, Kao C, Pfaller MA (1996) The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 22:14–20PubMedCrossRef Herwaldt LA, Magdalena G, Kao C, Pfaller MA (1996) The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 22:14–20PubMedCrossRef
5.
go back to reference Khatib R, Riederer KM, Clark JA, Khatib S, Briski LE, Wilson FM (1995) Coagulase-negative staphylococci in multiple blood cultures: strain relatedness and determinants of same-strain bacteremia. J Clin Microbiol 33:816–820PubMed Khatib R, Riederer KM, Clark JA, Khatib S, Briski LE, Wilson FM (1995) Coagulase-negative staphylococci in multiple blood cultures: strain relatedness and determinants of same-strain bacteremia. J Clin Microbiol 33:816–820PubMed
6.
go back to reference Thylefors JD, Harbarth S, Pittet D (1998) Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol 19:581–589PubMedCrossRef Thylefors JD, Harbarth S, Pittet D (1998) Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol 19:581–589PubMedCrossRef
7.
go back to reference Seo SK, Venkataraman L, DeGirolami PC, Samore MH (2000) Molecular typing of coagulase-negative staphylococci from blood cultures does not correlate with clinical criteria for true bacteremia. Am J Med 109:697–704PubMedCrossRef Seo SK, Venkataraman L, DeGirolami PC, Samore MH (2000) Molecular typing of coagulase-negative staphylococci from blood cultures does not correlate with clinical criteria for true bacteremia. Am J Med 109:697–704PubMedCrossRef
8.
go back to reference Heiden G (1996) A comparison of methods to determine whether clinical isolates of Staphylococcus epidermidis from the same patient are related. J Hosp Infect 34:31–42CrossRef Heiden G (1996) A comparison of methods to determine whether clinical isolates of Staphylococcus epidermidis from the same patient are related. J Hosp Infect 34:31–42CrossRef
9.
go back to reference Tan TQ, Musser JM, Shulman RJ, Mason EO Jr, Mahoney DH Jr, Kaplan SL (1994) Molecular epidemiology of coagulase-negative Staphylococcus blood isolates from neonates with persistent bacteremia and children with central venous catheter infections. J Infect Dis 169:1393–1397PubMedCrossRef Tan TQ, Musser JM, Shulman RJ, Mason EO Jr, Mahoney DH Jr, Kaplan SL (1994) Molecular epidemiology of coagulase-negative Staphylococcus blood isolates from neonates with persistent bacteremia and children with central venous catheter infections. J Infect Dis 169:1393–1397PubMedCrossRef
10.
go back to reference Toldos CM, Yague G, Ortiz G, Segovia M (1997) Assessment of multiple coagulase-negative staphylococci isolated in blood cultures using pulsed-field gel electrophoresis. Eur J Clin Microbiol Infect Dis 16:581–586PubMedCrossRef Toldos CM, Yague G, Ortiz G, Segovia M (1997) Assessment of multiple coagulase-negative staphylococci isolated in blood cultures using pulsed-field gel electrophoresis. Eur J Clin Microbiol Infect Dis 16:581–586PubMedCrossRef
11.
go back to reference Tardieu C, Cowen D, Thirion X, Franquin JC (1996) Quantitative scale of oral mucositis associated with autologous bone marrow transplantation. Eur J Cancer 32:381–387 Tardieu C, Cowen D, Thirion X, Franquin JC (1996) Quantitative scale of oral mucositis associated with autologous bone marrow transplantation. Eur J Cancer 32:381–387
12.
go back to reference Takahashi K, Soga Y, Murayama Y et al (2010) Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen. Support Care Cancer. doi: 10.1007/s00520-009-0637-z Takahashi K, Soga Y, Murayama Y et al (2010) Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen. Support Care Cancer. doi: 10.​1007/​s00520-009-0637-z
13.
go back to reference Hughes WT, Armstrong D, Bodey GP et al (2002) Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730PubMedCrossRef Hughes WT, Armstrong D, Bodey GP et al (2002) Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730PubMedCrossRef
14.
go back to reference Sonis ST, Oster G, Fuchs H et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205PubMed Sonis ST, Oster G, Fuchs H et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205PubMed
15.
go back to reference Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39PubMed Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39PubMed
16.
go back to reference Amerongen AV, Veerman EC (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11:226–231 Amerongen AV, Veerman EC (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11:226–231
17.
go back to reference Jensen SB, Pedersen AM, Reibel J, Nauntofte B (2003) Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 11:207–225PubMed Jensen SB, Pedersen AM, Reibel J, Nauntofte B (2003) Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 11:207–225PubMed
18.
go back to reference Sugiura Y, Soga Y, Nishide S et al (2008) Evaluation of xerostomia in hematopoietic cell transplantation by a simple capacitance method device. Support Care Cancer 16:1197–1200PubMedCrossRef Sugiura Y, Soga Y, Nishide S et al (2008) Evaluation of xerostomia in hematopoietic cell transplantation by a simple capacitance method device. Support Care Cancer 16:1197–1200PubMedCrossRef
19.
go back to reference Cervera C, Almela M, Martínez-Martínez JA, Moreno A, Miró JM (2009) Risk factors and management of Gram-positive bacteraemia. Int J Antimicrob Agents 34(Suppl 4):S26–S30PubMedCrossRef Cervera C, Almela M, Martínez-Martínez JA, Moreno A, Miró JM (2009) Risk factors and management of Gram-positive bacteraemia. Int J Antimicrob Agents 34(Suppl 4):S26–S30PubMedCrossRef
20.
go back to reference Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y (2009) Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 49:1187–1194PubMedCrossRef Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y (2009) Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 49:1187–1194PubMedCrossRef
21.
go back to reference Kennedy HF, Morrison D, Kaufmann ME et al (2000) Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient. J Med Microbiol 49:367–370PubMed Kennedy HF, Morrison D, Kaufmann ME et al (2000) Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient. J Med Microbiol 49:367–370PubMed
22.
go back to reference Blijlevens NM, Donnelly JP, de Pauw BE (2001) Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy. Clin Microbiol Infect 7(Suppl 4):47–52PubMedCrossRef Blijlevens NM, Donnelly JP, de Pauw BE (2001) Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy. Clin Microbiol Infect 7(Suppl 4):47–52PubMedCrossRef
23.
go back to reference Costa SF, Miceli MH, Anaissie EJ (2004) Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? Lancet Infect Dis 4:278–286PubMedCrossRef Costa SF, Miceli MH, Anaissie EJ (2004) Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? Lancet Infect Dis 4:278–286PubMedCrossRef
Metadata
Title
Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation
Authors
Yoshihiko Soga
Yoshinobu Maeda
Fumihiko Ishimaru
Mitsune Tanimoto
Hiroshi Maeda
Fusanori Nishimura
Shogo Takashiba
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 7/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0923-9

Other articles of this Issue 7/2011

Supportive Care in Cancer 7/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine